Decaprenoxanthin | 343608-29-7

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: Decaprenoxanthin
• 英文别名: Dehydrogenans-P439; 1,18-Bis-<2,2,6-trimethyl-3-(4-hydroxy-3-methylbut-2-enyl)-cyclohex-5-enyl>-3,7,12,16-tetramethyl-octadeca-1,3,5,7,9,11,13,15,17-nonaen；(2R,6R,2'R,6'R)-decaprenoxanthin；(E)-4-[5-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[5-[(E)-4-hydroxy-3-methylbut-2-enyl]-2,6,6-trimethylcyclohex-2-en-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-4,6,6-trimethylcyclohex-3-en-1-yl]-2-methylbut-2-en-1-ol
• CAS: 343608-29-7
• 化学式: C₅₀H₇₂O₂
• 分子量: 705.12
• InChiKey: FMUTWECJHLYSSS-DXAMSVBWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  14.5
• 重原子数：
  52
• 可旋转键数：
  16
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.48
• 拓扑面积：
  40.5
• 氢给体数：
  2
• 氢受体数：
  2

文献信息

• METHODS AND STRAINS FOR THE PRODUCTION OF SARCINAXANTHIN AND DERIVATIVES THEREOF
  申请人：Promar AS

  公开号：EP2576603A1

  公开（公告）日：2013-04-10
• CAROTENOID PARTICLES AND USES THEREOF
  申请人：IP Science Limited

  公开号：EP2670392B1

  公开（公告）日：2020-11-11
• COMPOSITIONS COMPRISING CAROTENOIDS AND PHOSPHATIDYLCHOLINE
  申请人：IP Science Limited

  公开号：EP3532027A1

  公开（公告）日：2019-09-04
• INTELLIGENT DELIVERY OF INGESTED AND ABSORBED MOLECULES
  申请人：Immd SP. Zo.o

  公开号：EP3534884A1

  公开（公告）日：2019-09-11
• INTELIGENT DELIVERY OF INGESTED AND ABSORBED MOLECULES
  申请人：IMMD SP. ZO.O

  公开号：US20200261482A1

  公开（公告）日：2020-08-20

  The present application is concerned with methods for increasing the bioavailability and/or activity of agents and in particular allows selective targeting of an agent to, or via, the liver or allows the liver to be bypassed. By selecting which of saturated fatty acids (SFA), short chain fatty acids (SCFA), medium chain fatty acids (MCFA), polyunsaturated fatty acids (PUFA), monounsaturated fatty acids (MUFAs) and long chain fatty acids (LCFA) are present in a composition and which predominates it is possible to substantially boost bioavailability and also to selectively target whether an agent is delivered to, or via, the liver or alternatively bypasses the liver. The approach is a versatile platform technology which may be applied to agents in general helping achieve better and more efficient delivery. In one preferred embodiment particular carotenoids are employed to further influence whether delivery is to, or via, the liver, or bypasses the liver.